Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 1
1982 1
1983 1
1985 1
1990 2
1991 6
1992 5
1993 4
1994 4
1995 5
1996 1
1997 4
2000 2
2001 3
2002 2
2004 1
2005 2
2006 3
2007 5
2008 3
2009 2
2010 10
2011 8
2012 8
2013 11
2014 11
2015 8
2016 6
2017 8
2018 5
2019 11
2020 18
2021 13
2022 13
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group. Ridker PM, et al. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28845751 Free article. Clinical Trial.
Developmental Language Disorder: Early Predictors, Age for the Diagnosis, and Diagnostic Tools. A Scoping Review.
Sansavini A, Favilla ME, Guasti MT, Marini A, Millepiedi S, Di Martino MV, Vecchi S, Battajon N, Bertolo L, Capirci O, Carretti B, Colatei MP, Frioni C, Marotta L, Massa S, Michelazzo L, Pecini C, Piazzalunga S, Pieretti M, Rinaldi P, Salvadorini R, Termine C, Zuccarini M, D'Amico S, De Cagno AG, Levorato MC, Rossetto T, Lorusso ML. Sansavini A, et al. Brain Sci. 2021 May 17;11(5):654. doi: 10.3390/brainsci11050654. Brain Sci. 2021. PMID: 34067874 Free PMC article. Review.
H(2)S- and NO-releasing gasotransmitter platform: A crosstalk signaling pathway in the treatment of acute kidney injury.
Pieretti JC, Junho CVC, Carneiro-Ramos MS, Seabra AB. Pieretti JC, et al. Pharmacol Res. 2020 Nov;161:105121. doi: 10.1016/j.phrs.2020.105121. Epub 2020 Aug 14. Pharmacol Res. 2020. PMID: 32798649 Free PMC article. Review.
Both H(2)S and NO are endogenous signalling molecules involved in several physiological and pathophysiological processes, such as the ones taking place in the renal system. ...Since these gasotransmitters are found in gaseous state at environmental conditions, they can be …
Both H(2)S and NO are endogenous signalling molecules involved in several physiological and pathophysiological processes, such as the …
FMRP RNA targets: identification and validation.
Darnell JC, Mostovetsky O, Darnell RB. Darnell JC, et al. Genes Brain Behav. 2005 Aug;4(6):341-9. doi: 10.1111/j.1601-183X.2005.00144.x. Genes Brain Behav. 2005. PMID: 16098133 Free article. Review.
The Fragile X Syndrome is caused by the loss of function of the FMR1 gene (Pieretti et al. 1991. Cell 66, 817-822; O'Donnell & Warren 2002. Annu Rev Neurosci 25, 315-338]. ...
The Fragile X Syndrome is caused by the loss of function of the FMR1 gene (Pieretti et al. 1991. Cell 66, 817-822; O'Donnell & Wa …
Crocus Sativus L. (Saffron) in Alzheimer's Disease Treatment: Bioactive Effects on Cognitive Impairment.
D'Onofrio G, Nabavi SM, Sancarlo D, Greco A, Pieretti S. D'Onofrio G, et al. Curr Neuropharmacol. 2021;19(9):1606-1616. doi: 10.2174/1570159X19666210113144703. Curr Neuropharmacol. 2021. PMID: 33441068 Free PMC article. Review.
(saffron) appears to own neuroprotective effects on cognitive impairment in patients with Alzheimer's disease (AD). The purpose of this work is to review evidence and mechanisms of saffron-induced therapeutic outcomes and measureable cognitive benefits in AD. ...As for the …
(saffron) appears to own neuroprotective effects on cognitive impairment in patients with Alzheimer's disease (AD). The purpose of th …
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function.
Saviano A, Manosour AA, Raucci F, Merlino F, Marigliano N, Schettino A, Wahid M, Begum J, Filer A, Manning JE, Casillo GM, Piccolo M, Ferraro MG, Marzano S, Russomanno P, Bellavita R, Irace C, Amato J, Alfaifi M, Rimmer P, Iqbal T, Pieretti S, Vellecco V, Caso F, Costa L, Giacomelli R, Scarpa R, Cirino G, Bucci M, McGettrick HM, Grieco P, Iqbal AJ, Maione F. Saviano A, et al. Ann Rheum Dis. 2023 Nov;82(11):1415-1428. doi: 10.1136/ard-2023-224479. Epub 2023 Aug 14. Ann Rheum Dis. 2023. PMID: 37580108 Free PMC article.
Pelvic Organ Prolapse Syndrome and Lower Urinary Tract Symptom Update: What's New?
Munno GM, La Verde M, Lettieri D, Nicoletti R, Nunziata M, Fasulo DD, Vastarella MG, Pennacchio M, Scalzone G, Pieretti G, Fortunato N, De Simone F, Riemma G, Torella M. Munno GM, et al. Healthcare (Basel). 2023 May 22;11(10):1513. doi: 10.3390/healthcare11101513. Healthcare (Basel). 2023. PMID: 37239801 Free PMC article. Review.
190 results